Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8833353 | Journal of the American College of Surgeons | 2018 | 44 Pages |
Abstract
Regardless of indication or type, pancreatectomy with AR is associated with risks greater than standard resections. Mortality has decreased in the modern era; however, morbidity remains high from hemorrhagic, fistula, or ischemia-related complications. Mitigation measures are needed if advanced resections are considered with increasing frequency given the potential oncologic benefit of AR in selected cases after modern chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
May C. MD, MPH, Adam C. MD, Ryan T. MD, Michael B. MD, FACS, David M. MD, FACS, Michael L. MD, FACS, Sean P. MD, FACS, Rory L. MD, FACS, Kristopher P. MD, MS, Mark J. MD, MS, FACS,